Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Blood Cancer Journal
|
March 27, 2021
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure
Jennifer J Gile, Camden L Lopez, Gordon J Ruan, et al.
Iscience
|
June 1, 2023
Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in patients with severe COVID-19
Xiaosheng Wu, Michelle K Manske, Gordon J Ruan, et al.
JCO Precision Oncology
|
November 22, 2024
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations
Katherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari, et al.
Blood Advances
|
September 12, 2023
Long-term outcomes among adults with Langerhans cell histiocytosis
Gaurav Goyal, Aldo A Acosta-Medina, Jithma P Abeykoon, et al.
JAMA Oncology
|
October 6, 2022
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status
Jithma P Abeykoon, Karen L Rech, Jason R Young, et al.
American Journal of Hematology
|
January 3, 2022
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease
Jithma P Abeykoon, Terra L Lasho, Surendra Dasari, et al.
Blood Advances
|
August 28, 2025
Cardiovascular Degeneration in Erdheim-Chester Disease: Prevalence, Burden, and Outcomes
Reema Kamal Tawfiq, Grant M Spears, Jason R Young, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Blood Cancer Journal
|
March 27, 2021
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure
Jennifer J Gile, Camden L Lopez, Gordon J Ruan, et al.
Iscience
|
June 1, 2023
Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in patients with severe COVID-19
Xiaosheng Wu, Michelle K Manske, Gordon J Ruan, et al.
JCO Precision Oncology
|
November 22, 2024
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations
Katherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari, et al.
Blood Advances
|
September 12, 2023
Long-term outcomes among adults with Langerhans cell histiocytosis
Gaurav Goyal, Aldo A Acosta-Medina, Jithma P Abeykoon, et al.
JAMA Oncology
|
October 6, 2022
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status
Jithma P Abeykoon, Karen L Rech, Jason R Young, et al.
American Journal of Hematology
|
January 3, 2022
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease
Jithma P Abeykoon, Terra L Lasho, Surendra Dasari, et al.
Blood Advances
|
August 28, 2025
Cardiovascular Degeneration in Erdheim-Chester Disease: Prevalence, Burden, and Outcomes
Reema Kamal Tawfiq, Grant M Spears, Jason R Young, et al.
Page
of 2